ELECTROMEDICAL TECHNOLOGIES, INC. Financials Electromedical Technologies, Inc.
Equities
EMED
US28540Q1004
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 USD | 0.00% |
|
-37.50% | -28.57% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 36.48 | 8.436 | 5.888 | 1.283 | 0.3242 |
| Enterprise Value (EV) 1 | 38.95 | 9.542 | 7.077 | 2.891 | 1.935 |
| P/E ratio | -19.8 x | -1.73 x | -0.28 x | -0.25 x | -0.1 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 44 x | 11.4 x | 6.49 x | 1.12 x | 0.24 x |
| EV / Revenue | 46.9 x | 12.9 x | 7.8 x | 2.51 x | 1.43 x |
| EV / EBITDA | -23.7 x | -3.03 x | -1.87 x | -1.83 x | -0.94 x |
| EV / FCF | 1,72,331 x | 10.3 x | 13.4 x | 4.28 x | -5.18 x |
| FCF Yield | 0% | 9.75% | 7.46% | 23.4% | -19.3% |
| Price to Book | -14.5 x | -4.87 x | -5.42 x | -0.49 x | -0.09 x |
| Nbr of stocks (in thousands) | 17,797 | 28,118 | 88,472 | 1,91,531 | 4,63,115 |
| Reference price 2 | 2.050 | 0.3000 | 0.0666 | 0.006700 | 0.000700 |
| Announcement Date | 08/05/20 | 30/03/21 | 31/03/22 | 31/03/23 | 01/05/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.6754 | 0.8297 | 0.738 | 0.9074 | 1.15 | 1.349 |
| EBITDA 1 | -0.2584 | -1.644 | -3.145 | -3.778 | -1.582 | -2.06 |
| EBIT 1 | -0.2807 | -1.669 | -3.167 | -3.8 | -1.604 | -2.065 |
| Operating Margin | -41.56% | -201.1% | -429.11% | -418.83% | -139.46% | -153.09% |
| Earnings before Tax (EBT) 1 | -1.95 | -1.744 | -3.872 | -8.48 | -3.468 | -2.641 |
| Net income 1 | -1.95 | -1.744 | -3.872 | -8.48 | -3.468 | -2.641 |
| Net margin | -288.79% | -210.23% | -524.65% | -934.59% | -301.65% | -195.82% |
| EPS 2 | -0.1283 | -0.1038 | -0.1736 | -0.2403 | -0.0268 | -0.007011 |
| Free Cash Flow 1 | -0.5842 | 0.000226 | 0.9299 | 0.5276 | 0.6757 | -0.3733 |
| FCF margin | -86.5% | 0.03% | 126.02% | 58.15% | 58.76% | -27.68% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 12/11/19 | 08/05/20 | 30/03/21 | 31/03/22 | 31/03/23 | 01/05/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 2.6 | 2.46 | 1.11 | 1.19 | 1.61 | 1.61 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -10.05 x | -1.499 x | -0.3518 x | -0.3147 x | -1.017 x | -0.7818 x |
| Free Cash Flow 1 | -0.58 | 0 | 0.93 | 0.53 | 0.68 | -0.37 |
| ROE (net income / shareholders' equity) | 134% | 82.2% | 221% | 831% | 236% | 104% |
| ROA (Net income/ Total Assets) | -16.3% | -111% | -171% | -169% | -72.7% | -123% |
| Assets 1 | 11.99 | 1.574 | 2.269 | 5.033 | 4.768 | 2.151 |
| Book Value Per Share 2 | -0.1300 | -0.1400 | -0.0600 | -0.0100 | -0.0100 | -0.0100 |
| Cash Flow per Share | - | - | 0.0100 | 0 | 0 | 0 |
| Capex | - | - | - | - | - | 0.15 |
| Capex / Sales | - | - | - | - | - | 11.1% |
| Announcement Date | 12/11/19 | 08/05/20 | 30/03/21 | 31/03/22 | 31/03/23 | 01/05/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -28.57% | 267K | |
| +11.29% | 225B | |
| +8.76% | 186B | |
| +12.90% | 135B | |
| +25.95% | 107B | |
| +0.49% | 63.56B | |
| +11.08% | 51.04B | |
| +5.62% | 51.32B | |
| +6.28% | 43.3B | |
| +4.80% | 36.99B |
- Stock Market
- Equities
- EMED Stock
- Financials Electromedical Technologies, Inc.